Immunodiagnostic Systems Holdings plc provided revenue guidance for the year ended March 31, 2015. Total revenues are expected to be £45 million (2014: £52 million) in line with guidance given in September 2014. The decrease in revenue was driven by lower automated revenues, due to a low level of net placements, and continued significant decline in manual revenues, predominantly in 25OH vitamin D.
Immunodiagnostic Systems Holdings PLC
Equities
IDH
GB00B01YZ052
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
-6.41% | 12.2B | |
-4.07% | 8.22B | |
+5.77% | 5.72B | |
+27.53% | 5.42B | |
-59.97% | 2.7B | |
+8.04% | 2.63B | |
-6.47% | 2.38B | |
+22.31% | 2.1B | |
-8.15% | 1.81B |